|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/08 | |
| C07B 59/00 | |||
| A61K 31/439 | |||
| A61P 11/14 |
| (11) | Number of the document | 3093290 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16163718.6 |
| Date of filing the European patent application | 2008-04-30 | |
| (97) | Date of publication of the European application | 2016-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 915130 P | 2007-05-01 | US | |
| 916662 P | 2007-05-08 | US | |
| 976044 P | 2007-09-28 | US |
| (72) |
TUNG, Roger, US
|
| (73) |
Concert Pharmaceuticals Inc.,
99 Hayden Avenue, Suite 500, Lexington, MA 02421,
US
|
| (54) | MORPHINAN COMPOUNDS |
| MORPHINAN COMPOUNDS |